News

MBDA Completes Sea Venom / ANL Missile Qualification Firing Trials
MBDA Completes Sea Venom / ANL Missile Qualification Firing Trials

The Sea Venom/ANL anti-ship missile has completed its qualification firings trials, with a successful final firing at the French Armament General Directorate (DGA) test site at Ile du Levant on November 17th 2020. Soon to start equipping the Royal Navy’s AW159 Wildcat and Marine Nationale’s H160M Guépard shipborne helicopters, the Sea Venom/ANL anti-ship missile is a co-operation

more
MBDA Inc Coronavirus Update
MBDA Inc Coronavirus Update

At MBDA, the health and safety of our people has always been a top priority. In coordination with our global partners, we are monitoring advice from federal, state, and local governments, as well as the Centers for Disease Control and the World Health Organization to ensure we are taking the right actions to protect our

more
MBDA Inc Exhibiting at 2019 Tailhook Conference
MBDA Inc Exhibiting at 2019 Tailhook Conference

As the worldwide leader in missile systems, MBDA is committed to supporting armed forces worldwide in bringing advanced weapons systems that complement the 5th generation F-35 Joint Strike Fighter. MBDA will be exhibiting at the 2019 Tailhook Association conference taking place September 5-8 in Reno, Nevada. In May 2019, a team of engineers from BAE

more
MBDA’s Sea Venom-ANL Missile Achieves New Milestone
MBDA’s Sea Venom-ANL Missile Achieves New Milestone

MBDA’s Sea Venom-ANL anti-ship missile has successfully conducted a further firing trial, highlighting Sea Venom-ANL’s lock on before launch (LOBL) capabilities, with images from the missile’s infrared seeker being used by the operator to designate the target prior to launch. The trial, conducted on November 14, 2018 from a DGA Dauphin test helicopter, was the

more